Steel Dynamics (STLD) Provides Second Quarter 2025 Earnings Guidance
Get Alerts STLD Hot Sheet
Join SI Premium – FREE
Steel Dynamics, Inc. (NASDAQ/GS: STLD) today provided second quarter 2025 earnings guidance in the range of
Second quarter 2025 profitability from the company's steel operations is expected to be significantly stronger than sequential first quarter results, as metal spreads expanded across the platform with average realized steel pricing increasing more than scrap raw material costs. Long product steel shipments improved sequentially in the quarter, with flat rolled volumes contracting modestly due primarily to the inventory overhang from coated flat rolled steel imports. The energy, non-residential construction, automotive, and industrial sectors continue to lead demand. Steel segment pretax earnings were reduced in the second quarter 2025 by approximately
Second quarter 2025 earnings from the company's metals recycling operations are expected to be steady sequentially, based on stronger shipments offsetting lower realized pricing.
Second quarter 2025 earnings from the company's steel fabrication operations are expected to be lower than sequential first quarter results, based on steady shipments combined with metal spread compression as steel raw material costs increased and the average realized sales price modestly declined. The pace of order activity increased in the quarter, and the order backlog improved, extending through 2025, with attractive related pricing levels. Demand was supported largely by the commercial, data center, manufacturing, warehouse, and healthcare sectors. Further, the accelerated announcements for meaningful domestic manufacturing investment and onshoring, coupled with the
The aluminum team is continuing with successful commissioning of the company's
As of
The company plans to release its second quarter 2025 earnings after the markets close on
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Akari Therapeutics shares preclinical data for AKTX-101 in urothelial cancer
Create E-mail Alert Related Categories
Corporate News, Guidance, Hot Corp. News, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share